An Open-label, Randomized, Single Dose, Three-way Crossover Study to Determine the Comparative Bioavailability of Two Fixed Dose Combination Tablet Formulations of Amlodipine (5mg) and Losartan (100mg) in Healthy Adult Male and Female Subjects Under Fasting Conditions
Phase of Trial: Phase I
Latest Information Update: 28 Jul 2017
At a glance
- Drugs Amlodipine/losartan (Primary) ; Amlodipine; Losartan
- Indications Hypertension
- Focus Pharmacokinetics
- Sponsors GlaxoSmithKline
- 01 Sep 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 17 Aug 2012 Actual initiation date (Aug 2012) added as reported by ClinicalTrials.gov.
- 01 Aug 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.